Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Annovis Bio Inc
(NY:
ANVS
)
8.430
-0.040 (-0.47%)
Streaming Delayed Price
Updated: 9:33 AM EDT, Sep 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Annovis Bio Inc
< Previous
1
2
3
4
5
Next >
Ignore Biogen: 3 Reasons These Stocks Will Be Better Alzheimer's Investments
June 11, 2021
Data doesn't lie. These companies have the potential to quickly steal the spotlight.
Via
The Motley Fool
Exposures
Product Safety
This Biotech Stock Is Up 884% In 2021, But It Could Go Even Higher
June 10, 2021
With updates from clinical trials expected as soon as this month, anything is possible.
Via
The Motley Fool
Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use?
June 08, 2021
Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure.
Via
Investor's Business Daily
Annovis' Alzheimer's/Parkinson's Candidate Protects Nerve Cells Against Ill Effects of Higher Neurotoxic Proteins
June 08, 2021
Annovis Bio Inc (NYSE: ANVS) has announced preliminary data demonstrating that ANVS401 protects certain nerve cells from dying after being infected by gingipains, which...
Via
Benzinga
Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You Rich
June 07, 2021
There are better options for investors looking to profit from potential Alzheimer's disease treatments.
Via
The Motley Fool
Exposures
Product Safety
Why Is Annovis Bio's Stock Surging Higher Today?
May 21, 2021
Annovis Bio Inc (NYSE:ANVS) shares are trading higher b...
Via
Benzinga
Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab
June 07, 2021
The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.
Via
Investor's Business Daily
Exposures
Product Safety
68 Biggest Movers From Yesterday
June 02, 2021
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached...
Via
Benzinga
54 Biggest Movers From Yesterday
May 26, 2021
Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended...
Via
Benzinga
22 Stocks Moving in Monday's Pre-Market Session
May 24, 2021
Gainers Virgin Galactic Holdings, Inc. (NYSE: SPCE) rose 29.3% to $27.25 in pre-market trading. Virgin Galactic’s VSS Unity spacecraft completed its first spaceflight from...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises
May 24, 2021
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones surged over 100 points in the previous session. Investors are awaiting earnings...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
48 Biggest Movers From Friday
May 24, 2021
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug...
Via
Benzinga
5 Stocks To Watch For May 24, 2021
May 24, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Nordson Corporation (NASDAQ: NDSN) to report quarterly earnings at $1.64 per share on revenue of $...
Via
Benzinga
Mid-Afternoon Market Update: Dow Rises 150 Points; VF Corp Shares Fall On Downbeat Earnings
May 21, 2021
Toward the end of trading Friday, the Dow traded up 0.44% to 34,234 while the NASDAQ fell 0.26% to 13,500.91. The S&P also rose, gaining 0.07% to 4,161.93. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mid-Day Market Update: Nasdaq Turns Lower; Annovis Bio Shares Surge
May 21, 2021
Midway through trading Friday, the Dow traded up 0.71% to 34,327.47 while the NASDAQ fell 0.12% to 13,520.12. The S&P also rose, gaining 0.35% to 4,173.78. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
30 Stocks Moving In Friday's Mid-Day Session
May 21, 2021
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares jumped 105.4% to $54.23 after the company announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401,...
Via
Benzinga
Annovis Bio Stock Rockets As Alzheimer's Drug Tops Biogen, Cassava Sciences
May 21, 2021
Annovis Bio said Friday its experimental Alzheimer's and Parkinson's treatment improved cognition in less than a month, leading ANVS stock to soar.
Via
Investor's Business Daily
Mid-Morning Market Update: Markets Open Higher; Deere Beats Q2 Estimates
May 21, 2021
Following the market opening Friday, the Dow traded up 0.84% to 34,370.30 while the NASDAQ rose 0.37% to 13,585.45. The S&P also rose, gaining 0.58% to 4,183.17. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Annovis Bio's Stock Trading Higher As Alzheimer's/Parkinson's Candidate Shows Cognitive Improvement
May 21, 2021
Annovis Bio Inc (NYSE: ANVS) has announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401, for Alzheimer's disease (AD),...
Via
Benzinga
64 Biggest Movers From Yesterday
May 11, 2021
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3....
Via
Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.